FI70721C - Foerfarande foer framstaellning av maenskligt fibroblast-interferon som homigent protein - Google Patents

Foerfarande foer framstaellning av maenskligt fibroblast-interferon som homigent protein Download PDF

Info

Publication number
FI70721C
FI70721C FI802400A FI802400A FI70721C FI 70721 C FI70721 C FI 70721C FI 802400 A FI802400 A FI 802400A FI 802400 A FI802400 A FI 802400A FI 70721 C FI70721 C FI 70721C
Authority
FI
Finland
Prior art keywords
interferon
column
sio
process according
hplc
Prior art date
Application number
FI802400A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI802400A (fi
FI70721B (fi
Inventor
Heinz-Juergen Friesen
Sidney Pestka
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI802400A publication Critical patent/FI802400A/fi
Application granted granted Critical
Publication of FI70721B publication Critical patent/FI70721B/fi
Publication of FI70721C publication Critical patent/FI70721C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FI802400A 1979-07-31 1980-07-31 Foerfarande foer framstaellning av maenskligt fibroblast-interferon som homigent protein FI70721C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6237179A 1979-07-31 1979-07-31
US6237179 1979-07-31
US13063580A 1980-03-14 1980-03-14
US13063580 1980-03-14

Publications (3)

Publication Number Publication Date
FI802400A FI802400A (fi) 1981-02-01
FI70721B FI70721B (fi) 1986-06-26
FI70721C true FI70721C (fi) 1986-10-06

Family

ID=26742182

Family Applications (1)

Application Number Title Priority Date Filing Date
FI802400A FI70721C (fi) 1979-07-31 1980-07-31 Foerfarande foer framstaellning av maenskligt fibroblast-interferon som homigent protein

Country Status (33)

Country Link
US (1) US5015730A (xx)
JP (1) JPH02138226A (xx)
AR (1) AR229931A1 (xx)
AT (1) AT372387B (xx)
AU (1) AU536274B2 (xx)
CA (1) CA1146468A (xx)
CH (1) CH648331A5 (xx)
DE (1) DE3028919A1 (xx)
DK (1) DK159825C (xx)
DO (1) DOP1980002948A (xx)
ES (1) ES8200560A1 (xx)
FI (1) FI70721C (xx)
FR (1) FR2462167B1 (xx)
GB (1) GB2055384B (xx)
HK (1) HK40384A (xx)
HU (1) HU185382B (xx)
IE (1) IE50075B1 (xx)
IL (1) IL60697A (xx)
IT (1) IT1132269B (xx)
KE (1) KE3364A (xx)
LU (1) LU82673A1 (xx)
MC (1) MC1337A1 (xx)
MY (1) MY8500274A (xx)
NL (1) NL8004361A (xx)
NO (1) NO151158C (xx)
NZ (1) NZ194495A (xx)
PH (2) PH17738A (xx)
PT (1) PT71625B (xx)
RO (1) RO81474B (xx)
SE (1) SE466290B (xx)
YU (1) YU193480A (xx)
ZA (1) ZA803943B (xx)
ZW (1) ZW17980A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI88175C (fi) 1980-04-03 1993-04-13 Biogen Inc Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon
IL63916A0 (en) * 1980-09-25 1981-12-31 Genentech Inc Microbial production of human fibroblast interferon
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
US4966843A (en) * 1982-11-01 1990-10-30 Cetus Corporation Expression of interferon genes in Chinese hamster ovary cells
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4894330A (en) * 1986-12-23 1990-01-16 Cetus Corporation Purification of recombinant beta-interferon incorporating RP-HPLC
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
US20050002902A1 (en) * 1995-12-28 2005-01-06 Liming Yu Hybrid with interferon-alpha and an immunoglobulin Fc for treatment of tumors and viral infections
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
US20030026779A1 (en) * 1999-10-15 2003-02-06 Liming Yu Treatment of tumors and viral infections with a hybrid conjugate of interferon and an immunoglobulin Fc
RS57549B1 (sr) 2005-08-26 2018-10-31 Ares Trading Sa Proces za pripremu glikoziliranog interferona beta
CA2625978A1 (en) 2005-12-09 2007-06-14 Ares Trading S.A. Method for purifying fsh or a fsh mutant
CA2702448A1 (en) * 2007-10-22 2009-04-30 Merck Serono S.A. Method for purifying fc-fusion proteins
DE102009032179A1 (de) 2009-07-07 2011-01-13 Biogenerix Ag Verfahren zur Reinigung von Interferon beta

Also Published As

Publication number Publication date
HK40384A (en) 1984-05-18
HU185382B (en) 1985-01-28
PH17738A (en) 1984-11-23
MY8500274A (en) 1985-12-31
IT8023801A0 (it) 1980-07-30
IE50075B1 (en) 1986-02-05
IE801589L (en) 1981-01-31
CA1146468A (en) 1983-05-17
NO151158B (no) 1984-11-12
SE466290B (sv) 1992-01-27
NZ194495A (en) 1984-07-31
PH18479A (en) 1985-07-18
AT372387B (de) 1983-09-26
FR2462167A1 (fr) 1981-02-13
LU82673A1 (fr) 1982-02-17
RO81474A (ro) 1983-04-29
AU6091480A (en) 1981-02-05
YU193480A (en) 1984-04-30
DK159825B (da) 1990-12-10
DE3028919C2 (xx) 1988-02-18
SE8005498L (sv) 1981-02-01
ATA395080A (de) 1983-02-15
ZW17980A1 (en) 1981-03-18
DE3028919A1 (de) 1981-02-19
AR229931A1 (es) 1984-01-31
IT1132269B (it) 1986-07-02
IL60697A0 (en) 1980-09-16
MC1337A1 (fr) 1981-04-21
GB2055384B (en) 1983-08-10
IL60697A (en) 1984-04-30
GB2055384A (en) 1981-03-04
NO151158C (no) 1985-02-20
DK328880A (da) 1981-02-01
NL8004361A (nl) 1981-02-03
PT71625B (en) 1981-12-17
DOP1980002948A (es) 1989-04-20
FI802400A (fi) 1981-02-01
JPH02138226A (ja) 1990-05-28
CH648331A5 (de) 1985-03-15
ZA803943B (en) 1981-06-24
ES493849A0 (es) 1981-11-16
FR2462167B1 (fr) 1985-07-05
RO81474B (ro) 1983-04-30
US5015730A (en) 1991-05-14
PT71625A (en) 1980-08-01
FI70721B (fi) 1986-06-26
KE3364A (en) 1984-02-03
DK159825C (da) 1991-04-29
AU536274B2 (en) 1984-05-03
ES8200560A1 (es) 1981-11-16
NO802297L (no) 1981-02-02

Similar Documents

Publication Publication Date Title
US4289689A (en) Preparation of homogeneous human fibroblast interferon
FI70721C (fi) Foerfarande foer framstaellning av maenskligt fibroblast-interferon som homigent protein
Said et al. Isolation from porcine‐intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon
Jollès et al. The lysozyme from Asterias rubens
US4503035A (en) Protein purification process and product
Gospodarowicz Purification of a fibroblast growth factor from bovine pituitary.
Antoniades et al. Purification of human platelet-derived growth factor.
US4289690A (en) Protein purification process and product
Friesen et al. Purification and molecular characterization of human fibroblast interferon
US5196323A (en) Process for preparing and purifying alpha-interferon
NZ203364A (en) Method for purifying human immune interferon;homogeneous human immune interferon
US4617378A (en) Purification of biologically active human immune interferon
JPS6338330B2 (xx)
KR940010024B1 (ko) α-인터페론의 제조 및 정제 방법
Hobbs et al. [68] Purification of interferon produced in a culture of human granulocytes
KR840001516B1 (ko) 인체 섬유아세포 인터페론의 제조방법
US6307031B1 (en) Beta taipoxin as a cell growth factor and method
EP0675135A2 (en) Protein PHBP-70, having heparin binding and fibroblast proliferating properties
Herring et al. Rapid purification of leukocyte interferons by high-performance liquid chromatography

Legal Events

Date Code Title Description
MA Patent expired

Owner name: F. HOFFMANN-LA ROCHE AG